Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Market Closed - Nyse Other stock markets 04:00:05 2024-05-16 pm EDT			5-day change	1st Jan Change
322.7 ^USD	-1.30%		+0.25%	+19.22%

May. 14	DBS Bank Initiates HCA Healthcare at Buy Rating With $370 Price Target	MT
May. 13	Hca Healthcare Insider Sold Shares Worth $516,450, According to a Recent SEC Filing	MT

Evolution of the average Target Price on HCA Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ff0d98c5eb2fb4ab603aea78177.umxNFgY99qHPT1Fi25hrjbd4G546Z0ItgWfnmeSqYWI.4CodVGlUlef2Px8hvNYu6sctYscXFG9r9FWNzK2aVSvABnl_UVue9uIYYQ~7a6535ef16af1b31e4027e7d835ce36d

Analyst Recommendations on HCA Healthcare, Inc.

DBS Bank Initiates HCA Healthcare at Buy Rating With $370 Price Target	May. 14	MT
Hca Healthcare Insider Sold Shares Worth $516,450, According to a Recent SEC Filing	May. 13	MT
Hca Healthcare Insider Sold Shares Worth $1,999,825, According to a Recent SEC Filing	May. 13	MT
Hca Healthcare Insider Sold Shares Worth $494,400, According to a Recent SEC Filing	May. 08	MT
TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371	Apr. 30	MT
Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354	Apr. 29	MT
UBS Adjusts HCA Healthcare Price Target to $363 From $348, Maintains Buy Rating	Apr. 29	MT
RBC Capital Adjusts Price Target on HCA Healthcare to $329 From $322	Apr. 29	MT
Oppenheimer Adjusts HCA Healthcare Price Target to $345 From $330, Maintains Outperform Rating	Apr. 29	MT
Barclays Adjusts HCA Healthcare's Price Target to $367 From $356, Keeps Overweight Rating	Apr. 29	MT
Mizuho Adjusts Price Target on HCA Healthcare to $370 From $345	Apr. 22	MT
Truist Securities Adjusts Price Target on HCA Healthcare to $375 From $345	Apr. 15	MT
Deutsche Bank Adjusts HCA Healthcare Price Target to $359 From $330, Maintains Buy Rating	Apr. 12	MT
Wells Fargo Raises Price Target on HCA Healthcare to $315 From $303, Maintains Equalweight Rating	Mar. 28	MT
ANALYST RECOMMENDATIONS : Nasdaq, Stellantis, Clorox, Ulta Beauty, Standard Chartered...	Mar. 26
Hca Healthcare Insider Sold Shares Worth $400,057, According to a Recent SEC Filing	Mar. 21	MT
ANALYST RECOMMENDATIONS : Doordash, Microsoft, Roblox, Uber, Redrow...	Feb. 08
UBS Adjusts HCA Healthcare Price Target to $348 From $305, Maintains Buy Rating	Jan. 31	MT
Deutsche Bank Raises HCA Healthcare Price Target to $330 From $280, Maintains Buy Rating	Jan. 31	MT
Raymond James Raises Price Target on HCA Healthcare to $330 From $300, Maintains Outperform Rating	Jan. 31	MT
Oppenheimer Raises HCA Healthcare Price Target to $330 From $315, Maintains Outperform Rating	Jan. 31	MT
RBC Raises Price Target on HCA Healthcare to $322 From $308 Amid 'Impressive' Q4 Results, 2024 Guidance; Outperform Kept	Jan. 31	MT
RBC Raises Price Target on HCA Healthcare to $308 From $284, Keeps Outperform Rating	Jan. 24	MT
Bernstein Downgrades HCA Healthcare to Market Perform From Outperform, Price Target is $301	Jan. 04	MT
Goldman Sachs Downgrades HCA Healthcare to Neutral From Buy, Cuts Price Target to $271 From $281	Dec. 11	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

322.7 USD

Average target price

344.4 USD

Spread / Average Target

+6.71%

High Price Target

378 USD

Spread / Highest target

+17.13%

Low Price Target

285 USD

Spread / Lowest Target

-11.69%

Consensus detail

Consensus revision (last 18 months)

Analysts covering HCA Healthcare, Inc.

DBS Bank
TD Cowen
Leerink Partners
UBS
RBC Capital Markets
Oppenheimer
Barclays
Mizuho Securities
Truist Securities
Deutsche Bank Securities
Wells Fargo Securities
Raymond James
Bernstein
Goldman Sachs
Argus
JPMorgan Chase
Stephens Inc.
Baptista Research
Credit Suisse
Jefferies & Co.
Citigroup
BofA Securities
Loop Capital
Cantor Fitzgerald
Cowen
SVB Securities LLC
BMO Capital
SVB Leerink
Seaport Global Securities

Ratings for HCA Healthcare, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar